Toshiro Yonei

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03

Satoshi Teramukai, Toshiyuki Kitano, Yusuke Kishida et al. · European Journal of Cancer · 2009 · 339 citations

Advanced Lung Disease, Medicine, Immunology +7

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

Yoshihiko Segawa, Katsuyuki Kiura, Nagio Takigawa et al. · Journal of Clinical Oncology · 2010 · 246 citations · Full text

Interstitial Lung Disease in Japanese Patients With Non-Small Cell Lung Cancer Receiving Gefitinib

Katsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata et al. · The Cancer Journal · 2005 · 75 citations

Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa et al. · Journal of Thoracic Oncology · 2010 · 72 citations · Full text

Medicine, Pathology, Bronchial Neoplasm +6

Pulmonary Tumor Thrombotic Microangiopathy Diagnosed Antemortem and Treated with Combination Chemotherapy

Hiroe Kayatani, Kiyoshi Matsuo, Yusuke Ueda et al. · Internal Medicine · 2012 · 64 citations · Full text

Pathology, Pulmonary Hypertension, Lung Biopsy +18